课题基金 / 基金详情

Study on the pathogenesis and mechanism of the development of thyroid-associated ophthalmopathy

Study on the pathogenesis and mechanism of the development of thyroid-associated ophthalmopathy
甲状腺相关性眼病发病机制及发生机制研究
批准号:
17590971
负责人:
HIROMATSU Yuji
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

HIROMATSU Yuji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have studied the pathogenesis and mechanism of the development of ophthalmopathy in Graves' disease.1) Susceptibility genes to thyroid-associated ophthalmmopathy (TAO)There are much evidence that cytokines, immunomodulators, transcription factors play important roles in the development of TAO.In association studies we have shown that the polymorphisms of the IL-18, ICAM-1 and NFkB1 genes were significantly associated with the development of ophthalmopathy. On the other hand, CTLA-4 gene and CD40 gene polymorphisms were associated with Graves' disease, but not with TAO.2) TSH receptor expression on the orbital fibroblasts and its modulation by nicotinamideA recent randomized controlled trail showed the usefulness of nicotinamide on TAO. We investigated the effect of nicotinamide on cultured orbital fibroblasts (preadipocytes) in adipogenesis and expressions of TSH receptor on the fibroblasts.We confirmed the expression of TSH receptor on orbital fibroblasts derived from patients with TAO. Pioglitazone, a PPARγ agonist, induced adiopogenesis and the expression of TSH receptor mRNA. Nicotinamide did not affect the expression of TSH receptor mRNA, but suppressed the proliferation of the fibroblasts.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
A new approach for Graves' ophthalmopathy
治疗格雷夫斯眼病的新方法
DOI: --
发表时间: 2006
期刊: Hormone and Research 54(8)
影响因子: --
作者: [田上哲也, 森山賢治, 臼井 健, 長田太助, 島津 章, 成瀬光栄, Hiromatsu Y, Araya K et al., Nagayama Y., Ito N et al., Hiromatsu Y]
通讯作者: Hiromatsu Y
【バセドウ病とその周辺疾患 基礎・臨床研究の最新動向】 特殊なバセドウ病 バセドウ病眼症の進展 ステロイド治療。
[格雷夫斯病及相关疾病基础和临床研究的最新动态] 特殊格雷夫斯病 格雷夫斯病眼病 类固醇治疗进展。
DOI: --
发表时间: 2006
期刊: 日本臨床 64巻12号
影响因子: --
作者: [Mikiya Miyazato, et al., 水野美邦, 広松雄治]
通讯作者: 広松雄治
【甲状腺疾患の新しい考え方】 バセドウ病眼症に対する新しい考え方
[甲状腺疾病的新思考方式]格雷夫斯眼病的新思考方式
DOI: --
发表时间: 2006
期刊: ホルモンと臨床 54巻8号
影响因子: --
作者: [Usui T, Izawa S, Sano T, Tagami T, Nagata D, Shimatsu A, Takahashi JA, Naruse M, 広松雄治]
通讯作者: 広松雄治
Role of anti-GAD antibody in Graves' ophthalmopathy
抗 GAD 抗体在格雷夫斯眼病中的作用
DOI: --
发表时间: 2005
期刊: Endocrinology and Diabetes 20(4)
影响因子: --
作者: [Hiromatsu Y, Mukai T, Kaku H, Miyake I]
通讯作者: Miyake I
18
    Genetic factors to Graves 'ophthalmopathy, other complications and the intractability to anti-thyroid drugs in patients with Graves' disease
    • 批准号:
      21591185
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      HIROMATSU Yuji
    • 依托单位:
    Study on the pathogenesis of Graves' ophthalmopathy
    • 批准号:
      15590988
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2003
    • 负责人:
      HIROMATSU Yuji
    • 依托单位:
    Study on the pathogenesis of thyroid-associated ophthalmopathy
    • 批准号:
      10671048
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1998
    • 负责人:
      HIROMATSU Yuji
    • 依托单位:
    Molecular biological study on the pathogenesis of thyroid-associated ophthalmopathy
    • 批准号:
      08671194
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1996
    • 负责人:
      HIROMATSU Yuji
    • 依托单位:
    海外基金